Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)
Background. The thyroid hormone metabolite 3-iodothyronamine (3-T1AM) is rapidly emerging as a promising compound in decreasing the heart rate and lowering the cardiac output. The aim of our study was to fully understand the molecular mechanism of 3-T1AM on cardiomyocytes and its potential targets i...
Main Authors: | Zhou Haiyan, Hu Bailong, Zhang Bei, Wang Yiming, Liu Xingde |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/1302453 |
Similar Items
-
Modulating Liver Cholesterol Metabolism by 3-Iodothyronamine
by: Nasrin KAZEMIPOUR, et al.
Published: (2017-07-01) -
The role of Relaxin-3 and 3-Iodothyronamine in the regulation of energy homeostasis
by: White, Nicholas Edward
Published: (2007) -
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases
by: Annunziatina Laurino, et al.
Published: (2018-06-01) -
Update on 3-iodothyronamine and its neurological and metabolic actions
by: Riccardo eZucchi, et al.
Published: (2014-10-01) -
3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes
by: Manuela Gencarelli, et al.
Published: (2020-05-01)